B D Havemann1, C A Henderson, H B El-Serag. 1. Section of Gastroenterology, Houston Department of Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Abstract
BACKGROUND AND AIMS: Gastro-oesophageal reflux disease (GORD) has been linked to a number of extra-esophageal symptoms and disorders, primarily in the respiratory tract. This systematic review aimed to provide an estimate of the strength and direction of the association between GORD and asthma. METHODS: Studies that assessed the prevalence or incidence of GORD in individuals with asthma, or of asthma in individuals with GORD, were identified in Medline and EMBASE via a systematic search strategy. RESULTS: Twenty-eight studies met the selection criteria. The sample size weighted average prevalence of GORD symptoms in asthma patients was 59.2%, whereas in controls it was 38.1%. In patients with asthma, the average prevalence of abnormal oesophageal pH, oesophagitis and hiatal hernia was 50.9%, 37.3% and 51.2%, respectively. The average prevalence of asthma in individuals with GORD was 4.6%, whereas in controls it was 3.9%. Pooling the odds ratios gave an overall ratio of 5.5 (95% CI 1.9-15.8) for studies reporting the prevalence of GORD symptoms in individuals with asthma, and 2.3 (95% CI 1.8-2.8) for those studies measuring the prevalence of asthma in GORD. One longitudinal study showed a significant association between a diagnosis of asthma and a subsequent diagnosis of GORD (relative risk 1.5; 95% CI 1.2-1.8), whereas the two studies that assessed whether GORD precedes asthma gave inconsistent results. The severity-response relationship was examined in only nine studies, with inconsistent findings. CONCLUSIONS: This systematic review indicates that there is a significant association between GORD and asthma, but a paucity of data on the direction of causality.
BACKGROUND AND AIMS: Gastro-oesophageal reflux disease (GORD) has been linked to a number of extra-esophageal symptoms and disorders, primarily in the respiratory tract. This systematic review aimed to provide an estimate of the strength and direction of the association between GORD and asthma. METHODS: Studies that assessed the prevalence or incidence of GORD in individuals with asthma, or of asthma in individuals with GORD, were identified in Medline and EMBASE via a systematic search strategy. RESULTS: Twenty-eight studies met the selection criteria. The sample size weighted average prevalence of GORD symptoms in asthmapatients was 59.2%, whereas in controls it was 38.1%. In patients with asthma, the average prevalence of abnormal oesophageal pH, oesophagitis and hiatal hernia was 50.9%, 37.3% and 51.2%, respectively. The average prevalence of asthma in individuals with GORD was 4.6%, whereas in controls it was 3.9%. Pooling the odds ratios gave an overall ratio of 5.5 (95% CI 1.9-15.8) for studies reporting the prevalence of GORD symptoms in individuals with asthma, and 2.3 (95% CI 1.8-2.8) for those studies measuring the prevalence of asthma in GORD. One longitudinal study showed a significant association between a diagnosis of asthma and a subsequent diagnosis of GORD (relative risk 1.5; 95% CI 1.2-1.8), whereas the two studies that assessed whether GORD precedes asthma gave inconsistent results. The severity-response relationship was examined in only nine studies, with inconsistent findings. CONCLUSIONS: This systematic review indicates that there is a significant association between GORD and asthma, but a paucity of data on the direction of causality.
Authors: D García-Compeán; M V González; G Galindo; D A Mar; J L Treviño; R Martínez; F Bosques; H Maldonado Journal: Dig Dis Date: 2000 Impact factor: 2.404
Authors: M D Mogica Martínez; E Paredes Cruz; M A Tenorio Pastrana; J Rodríguez Castellón; C Molina Ortiz; M del Rosario Canseco Raymundo; J L López Durán; M Becerril Angeles Journal: Rev Alerg Mex Date: 2001 Sep-Oct
Authors: A B R Thomson; A N Barkun; D Armstrong; N Chiba; R J White; S Daniels; S Escobedo; B Chakraborty; P Sinclair; S J O Veldhuyzen Van Zanten Journal: Aliment Pharmacol Ther Date: 2003-06-15 Impact factor: 8.171
Authors: Lakmali D Amarasiri; Arunasalam Pathmeswaran; H Janaka de Silva; Channa D Ranasinha Journal: BMC Pulm Med Date: 2010-09-15 Impact factor: 3.317